Home/Filings/4/0001104659-19-003723
4//SEC Filing

Einhorn Andrew J. 4

Accession 0001104659-19-003723

CIK 0001739426other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 5:49 PM ET

Size

5.8 KB

Accession

0001104659-19-003723

Insider Transaction Report

Form 4
Period: 2019-01-24
Einhorn Andrew J.
Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2019-01-24+104,849104,849 total
Holdings
  • Ordinary Shares

    (indirect: By family limited liability company)
    22,852
Footnotes (2)
  • [F1]Represents a grant of restricted stock units.
  • [F2]The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Osmotica Pharmaceuticals plc

CIK 0001739426

Entity typeother

Related Parties

1
  • filerCIK 0001560685

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:49 PM ET
Size
5.8 KB